The testimony at [the September 30th public hearing in New York City to examine the potential medicinal value and risks of psilocybin] makes it clear that psilocybin shows great promise for treating debilitating conditions like cluster headaches, depression, PTSD, and chronic pain, which have been resistant to traditional therapies, As we consider legislation to expand access in New York, our priority must be establishing framework that maximizes safety and ensures proper oversight for patients and providers.